Bacterial antigens representing 14 of the most common clinical isolates requiring serological confirmation for identification were prepared. These antigens were stable for periods in excess of 5 months, readily available, and sero-specific. Use of these antigens for quality control of bacterial typing antisera increased the accuracy, reduced the technician time, and obviated the delay which otherwise occurred while stock isolates were subcultured to provide a sero-specific control for this procedure.
Quality control of antisera used in the serogrouping and serotyping of bacteria is essential to insure effective and accurate use of the reagents involved. The inspection and accreditation protocol (2) published by the College of American Pathologists requires that each antiserum used in the identification of a bacterial species be quality controlled when initially purchased or constituted and at the time of each use. In many laboratories, this procedure requires that large numbers of bacterial serotypes be maintained for use on demand. However, the use of any given antigen is intermittent and depends on the volume and type of culture specimens received by the laboratory. Often the bacterial serotypes used as test antigens are maintained as lyophilized preparations which may result in a delay of up to several days before serological confirmation of bacterial isolates can be completed.
The need for sero-stable, nonviable antigens which can be made immediately available for bacterial identification is evident. Antigenic preparations of this type both could reduce the laboratory workload and would provide ongoing quality control, resulting in potentially improved accuracy of serotyping. The literature includes a number of reports on the preparation of bacterial antigens for the purpose of preparing specific antisera (1, 3, 4, 6, 7) . These reports usually deal with a single antigen and make no reference to the use or evaluation of such antigens in relation to the quality control of antisera. We, therefore, felt that information regarding the preparation and use of these antigens for insuring the continued potency and specificity of antisera would prove practical and were led to prepare such antigens for use with the sero- Bacteria were harvested by washing from the plates with 0.9% saline containing 0.5% Formalin. The suspension was then heated at 60°C for 1 h, filtered through nonabsorbent cotton, and centrifuged at 4°C for 15 min at 1,200 x g. The bacteria were washed three times by centrifugation with fresh Formalin-saline solution Shigella species listed in Table 1 were inoculated to Columbia agar containing 5% sheep erythrocytes and streaked for isolation. Individual smooth colonies were then selected and inoculated to Trypticase soy agar slants which were then incubated for 18 h. Bacterial growth from the slants was tested for agglutinability in specific antiserum. Cultures which agglutinated were then used to inoculate 100 ml of brain heart infusion broth (pH 7), which was incubated for 6 to 8 h. The bacteria were separated from the broth by centrifugation at 1,200 x g and suspended in 0.9% saline containing 0.5% Formalin. The suspension was then heated at 600C for 1 (6, 7) . Trypticase soy agar was inoculated, and the inoculum was streaked for isolation. Selected smooth colonies were then used to inoculate Trypticase soy agar slants which were incubated for 18 h. Growth from the Trypticase soy agar slants, which agglutinated in appropriate antiserum, was used to inoculate brain heart infusion agar slants which were then incubated for 18 h. To prepare the somatic antigens listed in Table 1 , growth from each slant was suspended in 0.9% saline containing ethanol and phenol at final concentrations of 25% and 0.125% respectively. The bacterial suspension was heated at 60°C for 45 min, fitered through nonabsorbent cotton, washed three times in 0.9% saline containing 0.5% phenol, suspended in 0.1 M phosphate buffer, pH 7, containing 0.01% Merthiolate, and then stored at 4°C. To prepare Vi antigen, the bacteria were harvested in 0.9% saline, washed, and suspended in 0.9% saline containing 0.5% Formalin. This suspension was held overnight at 40C, filtered through nonabsorbent cotton, washed, and suspended in 0.1 M phosphate buffer, pH 7, with 0.01% Merthiolate.
These procedures produced smooth, homogeneous bacterial suspensions which were stable for up to 5 months when stored at 40C. Other procedures, e.g., alcohol or acetone extraction, were attempted for preparation of Salmonella or Haemophilus antigens but yielded suspensions which were autoagglutinable, rough or unstable upon storage.
To determine the presence of agglutinins in antisera, the bacterial suspensions were mixed well, and a drop of the mixture was placed on a clean glass microscope slide. A drop of antiserum was added to the bacterial suspension and mixed thoroughly. Macroscopic agglutination was apparent in all instances in 15 to 30 s. When tested over a 5-month interval, these antigens consistently produced rapid, specific agglutination without false-positive cross-reactions in commercially available antisera. Saline controls (autoagglutination) were run with each test and were consistently negative. All the antigens noted in Table 1 were tested against each of the antisera used in this study, and no false-positive or -negative reactions were observed. When compared with viable cultures, the preserved bacterial antigens produced equally intense and rapid agglutination. However, use of the preserved bacteria produced a more uniform suspension, and therefore results were more easily determined. All antigen suspensions were tested by inoculating into brain heart infusion broth on September 26, 2017 by guest http://jcm.asm.org/ Downloaded from VOL. 11, 1980 and onto chocolate agar to insure organism nonviability. It would be very unlikely for organisms to survive the preparation process, and viability testing confirmed this expectation. Care is urged in the preparation of these antigens, since the viable cultures from which they derive are potentially pathogenic and can constitute an occupational hazard for microbiologists. However, once these suspensions have been prepared, they actually lessen the risk, in that viable organisms are not regularly needed for control purpose.
It is our observation that the use of preserved bacterial cultures for control of serological grouping and typing antisera is an efficient and economical practice and seems to be within the guidelines for bacteriological serology quality control procedures established by the College of American Pathologists (2) .
